Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
MOMETASONE FUROATE
B & S Healthcare
R01AD09
MOMETASONE FUROATE
50 Mcg/Acutuation
Nasal Spray Suspension
Product subject to prescription which may not be renewed (A)
corticosteroids
Authorised
2006-10-13
PACKAGE LEAFLET: INFORMATION FOR THE USER NASONEX ® 50MICROGRAMS/ACTUATION NASAL SPRAY, SUSPENSION (mometasone furoate) PLEASE READ THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Nasonex is and what it is used for 2. What you need to know before you use Nasonex 3. How to use Nasonex 4. Possible side effects 5. How to store Nasonex 6. Contents of the pack and other information 1. WHAT NASONEX IS AND WHAT IT IS USED FOR WHAT IS NASONEX? Nasonex Nasal Spray contains mometasone furoate, one of a group of medicines called corticosteroids. When mometasone furoate is sprayed into the nose, it can help to relieve inflammation (swelling and irritation of the nose), sneezing, itching and a blocked up or runny nose. WHAT IS NASONEX USED FOR? Hay fever and perennial rhinitis Nasonex is used to treat the symptoms of hayfever (also called seasonal allergic rhinitis) and perennial rhinitis in adults and children aged 3 and older. Hayfever, which occurs at certain times of the year, is an allergic reaction caused by breathing in pollen from trees, grasses, weeds and also moulds and fungal spores. Perennial rhinitis occurs throughout the year and symptoms can be c Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Nasonex 50 micrograms/actuation Nasal Spray, Suspension. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each actuation contains 50 micrograms mometasone furoate (as monohydrate) Excipients: Benzalkonium chloride For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Nasal spray, suspension. _Product imported from Portugal:_ White to off white opaque suspension 4 CLINICAL PARTICULARS As per PA1286/038/001 5 PHARMACOLOGICAL PROPERTIES As per PA1286/038/001 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Dispersible cellulose (microcrystalline cellulose & carmellose sodium) Glycerol Sodium citrate dihydrate Citric acid monohydrate Polysorbate 80 Purified water Benzalkonium chloride 6.2 INCOMPATIBILITIES Not applicable 6.3 SHELF LIFE The shelf life expiry date of this product is the date shown on the container and outer package of the product on the market in the country of origin. Discard two months after first opening. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 16/02/2015_ _CRN 2157305_ _page number: 1_ 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25°C. Do not freeze. 6.5 NATURE AND CONTENTS OF CONTAINER NASONEX Nasal Spray is contained in a white, high density polyethylene bottle, that contains 18 g (140 actuations) of product formulation, supplied with a metered-dose, manual polypropylene spray pump actuator. Each package contains one bottle. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special requirements 7 PARALLEL PRODUCT AUTHORISATION HOLDER B&S Healthcare Unit 4 Bradfield Road Ruislip Middlesex H Read the complete document